SPA
MD icon

Sherbrooke Park Advisers’s Pediatrix Medical MD Stock Holding History

Sherbrooke Park Advisers’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,774
Closed -$185K – 672
2025
Q1 		$185K Buy
12,774
+2,389
+23% +$33.9K 0.09% 435
2024
Q4 		$136K Buy
+10,385
New +$143K 0.04% 637
2023
Q3 		– Sell
-14,215
Closed -$202K – 576
2023
Q2 		$202K Buy
+14,215
New +$200K 0.11% 307

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sherbrooke Park Advisers's MD Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of Pediatrix Medical (MD) in Q2 2025, closing a stake of 12,774 shares — an estimated $185K sold.

Sherbrooke Park Advisers first reported a position in MD in Q2 2023 and held it in 3 quarters. The position peaked at $202K in Q2 2023. 264 funds tracked by Wall St. Rank hold MD as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining Pediatrix Medical position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 12,774 Pediatrix Medical shares in Q2 2025, an estimated $185K.
  • Sherbrooke Park Advisers first reported a position in Pediatrix Medical in Q2 2023 and held it in 3 quarters.
  • Sherbrooke Park Advisers's Pediatrix Medical position peaked at $202K in Q2 2023.
  • 264 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.